126 related articles for article (PubMed ID: 9439849)
1. Fluoxetine gradually increases [125I]DOI-labelled 5-HT2A/2C receptors in the hypothalamus without changing the levels of Gq- and G11-proteins.
Li Q; Muma NA; Battaglia G; Van de Kar LD
Brain Res; 1997 Nov; 775(1-2):225-8. PubMed ID: 9439849
[TBL] [Abstract][Full Text] [Related]
2. Delayed decreases in brain 5-hydroxytryptamine2A/2C receptor density and function in male rat progeny following prenatal fluoxetine.
Cabrera TM; Battaglia G
J Pharmacol Exp Ther; 1994 May; 269(2):637-45. PubMed ID: 8182530
[TBL] [Abstract][Full Text] [Related]
3. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist.
Li Q; Muma NA; van de Kar LD
J Pharmacol Exp Ther; 1996 Nov; 279(2):1035-42. PubMed ID: 8930214
[TBL] [Abstract][Full Text] [Related]
4. Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression.
Tilakaratne N; Yang Z; Friedman E
Eur J Pharmacol; 1995 Aug; 290(3):263-6. PubMed ID: 7589222
[TBL] [Abstract][Full Text] [Related]
5. Chronic fluoxetine differentially affects 5-hydroxytryptamine (2A) receptor signaling in frontal cortex, oxytocin- and corticotropin-releasing factor-containing neurons in rat paraventricular nucleus.
Damjanoska KJ; Van de Kar LD; Kindel GH; Zhang Y; D'Souza DN; Garcia F; Battaglia G; Muma NA
J Pharmacol Exp Ther; 2003 Aug; 306(2):563-71. PubMed ID: 12721328
[TBL] [Abstract][Full Text] [Related]
6. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
7. Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins.
Raap DK; Evans S; Garcia F; Li Q; Muma NA; Wolf WA; Battaglia G; Van De Kar LD
J Pharmacol Exp Ther; 1999 Jan; 288(1):98-106. PubMed ID: 9862759
[TBL] [Abstract][Full Text] [Related]
8. Autoradiographic evidence for differential G-protein coupling of 5-HT1A receptors in rat brain: lack of effect of repeated injections of fluoxetine.
Li Q; Battaglia G; Van de Kar LD
Brain Res; 1997 Sep; 769(1):141-51. PubMed ID: 9374282
[TBL] [Abstract][Full Text] [Related]
9. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter.
Kramer HK; Poblete JC; Azmitia EC
Neuropsychopharmacology; 1997 Sep; 17(3):117-29. PubMed ID: 9272479
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the functional heterologous desensitization of hypothalamic 5-HT(1A) receptors after 5-HT(2A) receptor activation.
Zhang Y; D'Souza D; Raap DK; Garcia F; Battaglia G; Muma NA; Van de Kar LD
J Neurosci; 2001 Oct; 21(20):7919-27. PubMed ID: 11588165
[TBL] [Abstract][Full Text] [Related]
11. Sustained desensitization of hypothalamic 5-Hydroxytryptamine1A receptors after discontinuation of fluoxetine: inhibited neuroendocrine responses to 8-hydroxy-2-(Dipropylamino)Tetralin in the absence of changes in Gi/o/z proteins.
Raap DK; Garcia F; Muma NA; Wolf WA; Battaglia G; van de Kar LD
J Pharmacol Exp Ther; 1999 Feb; 288(2):561-7. PubMed ID: 9918559
[TBL] [Abstract][Full Text] [Related]
12. Destruction of serotonergic nerve terminals prevents fluoxetine-induced desensitization of hypothalamic 5-HT(1A) receptors.
D'Souza DN; Zhang Y; Garcia F; Battaglia G; Van De Kar LD
Psychopharmacology (Berl); 2002 Dec; 164(4):392-400. PubMed ID: 12457269
[TBL] [Abstract][Full Text] [Related]
13. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
[TBL] [Abstract][Full Text] [Related]
14. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study.
Moorman JM; Leslie RA
Neuropharmacology; 1998; 37(3):357-74. PubMed ID: 9681934
[TBL] [Abstract][Full Text] [Related]
15. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
[TBL] [Abstract][Full Text] [Related]
16. Repeated DOI and SR 46349B treatments do not affect elevated plus-maze anxiety despite opposite effects on cortical 5-HT2A receptors.
Chaouloff F; Kulikov A; Mormède P
Eur J Pharmacol; 1997 Sep; 334(1):25-9. PubMed ID: 9346323
[TBL] [Abstract][Full Text] [Related]
17. Agonist-induced serotonin 2A receptor desensitization in the rat frontal cortex and hypothalamus.
Damjanoska KJ; Heidenreich BA; Kindel GH; D'Souza DN; Zhang Y; Garcia F; Battaglia G; Wolf WA; Van de Kar LD; Muma NA
J Pharmacol Exp Ther; 2004 Jun; 309(3):1043-50. PubMed ID: 14976228
[TBL] [Abstract][Full Text] [Related]
18. Evidence that 5-HT2A receptors in the hypothalamic paraventricular nucleus mediate neuroendocrine responses to (-)DOI.
Zhang Y; Damjanoska KJ; Carrasco GA; Dudas B; D'Souza DN; Tetzlaff J; Garcia F; Hanley NR; Scripathirathan K; Petersen BR; Gray TS; Battaglia G; Muma NA; Van de Kar LD
J Neurosci; 2002 Nov; 22(21):9635-42. PubMed ID: 12417689
[TBL] [Abstract][Full Text] [Related]
19. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
Asgari K; Body S; Bak VK; Zhang ZQ; Rickard JF; Glennon JC; Fone KC; Bradshaw CM; Szabadi E
Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
[TBL] [Abstract][Full Text] [Related]
20. LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT(1B/1D) receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat.
Mitchell SN; Greenslade RG; Cooper J
Eur J Pharmacol; 2001 Nov; 432(1):19-27. PubMed ID: 11734183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
